Last reviewed · How we verify

NCT03935412

The Analgesic Efficacy of Bilateral Erector Spinae Plane Block in Comparison With Intrathecal Morphine After Elective Cesarean Section

Completed NA Last updated 23 July 2019
What this trial tests

NA trial testing Erector Spinae Plane Block in Postoperative Pain in 140 participants. Completed in 5 July 2019.

Timeline
5 March 2019
Primary endpoint
1 July 2019
5 July 2019

Quick facts

Lead sponsorFayoum University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment140
Start date5 March 2019
Primary completion1 July 2019
Estimated completion5 July 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University

Who can join

Adults 18 to 40, female only, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to assess the analgesic efficacy of bilateral erector spinae plane block in comparison with intrathecal morphine after elective cesarean section under spinal anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Analgesic Efficacy of Erector Spinae Plane Block Compared with Intrathecal Morphine After Elective Cesarean Section: A Prospective Randomized Controlled Study.
    Hamed MA, Yassin HM, Botros JM, Abdelhady MA. · · 2020 · cited 27× · PMID 32273748 · DOI 10.2147/jpr.s242568

Verify or expand the search:

Other trials of Erector Spinae Plane Block

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Fayoum University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03935412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing